Mostly Markets
Subscribe
Stocks/Health Care/Health Care Facilities

HCA HealthcareHCA

Health Care Facilities · Nashville, Tennessee · In the S&P 500
$473.19−1.02%After hours: $476.90 (+0.78%)At the close, 30 Oct · Prices from CNBC, may be delayed
▲ 1.0% over 1 year
HCA Healthcare over 1 yearDaily close, $, to 30 Oct 2026
$400$450$500$550Nov2026MarMayJulSep$473.19$400$500NovMarJul$473.19
Source: Nasdaq daily closes
Market value$102B
Price to earnings15.7x
Forward P/E15.8x
Dividend yield0.66%
Year to date+1.4%
One year+1.0%
Next earningsNot scheduled
SectorHealth Care
52-week range (closes)
$361.32$545.13

Quality and valuation

How HCA Healthcare compares with other health care stocks. A description, not a recommendation.

HCA Healthcare and 5 health care facilities peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: weaker than mostValuation: in line with its sector

A weaker business than most health care companies, priced about in line with them.

HCA Healthcare trades at 15.8 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew slower than the sector median: +5.8% vs +7.8%
  • Turns less of its sales into cash: 7.6% vs 15.9%
  • Keeps less of its revenue as profit (net margin): 8.6% vs 9.7%
HCA trades at 15.8x forward earnings, below the sector medianForward p/e, Health Care Facilities peers
HCA15.8xNVS17.0xAZN17.5xMRK18.1xUNH18.9xABBV19.6xJNJ25.1xLLY36.3xSector median 19.1xHCA15.8xNVS17.0xAZN17.5xMRK18.1xUNH18.9xABBV19.6xJNJ25.1xLLY36.3xSector median 19.1x
Source: CNBC quotes; Mostly Markets
At 15.7x earnings, HCA is cheaper than its average since Oct 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
12x15x18x20xAverage 15.9x2025202615.7x15x20xAverage 15.9x2025202615.7x
Source: Nasdaq prices; SEC filings

Financials

From HCA Healthcare's SEC filings, through the quarter ending 30 Sep 2026. Hover or tap a bar for its value.

Revenue grew 3.6% from a year earlierQuarterly revenue, $bn, latest Q3 ’26
$0bn$10bn$20bnQ4 ’24Q2 ’25Q4 ’25$19.9bnQ3 ’26$0bn$10bn$20bnQ4 ’24Q2 ’25Q4 ’25$19.9bnQ3 ’26
Source: SEC filings
Growth slowed to +3.6% last quarterRevenue growth, year on year, %
0%2%5%8%Q4 ’24Q2 ’25Q4 ’253.6%Q3 ’260%5%Q4 ’24Q2 ’25Q4 ’253.6%Q3 ’26
Source: SEC filings
Free cash flow was $6.0 billion over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $bn
$0bn$1bn$2bn$3bnQ4 ’24Q2 ’25Q4 ’25$3.1bnQ3 ’26$0bn$2bnQ4 ’24Q2 ’25Q4 ’25$3.1bnQ3 ’26
Source: SEC filings
Diluted EPS was $7.27 last quarterQuarterly diluted earnings per share, $
$0$2$5$8Q4 ’24Q2 ’25Q4 ’25$7.27Q3 ’26$0$5Q4 ’24Q2 ’25Q4 ’25$7.27Q3 ’26
Source: SEC filings
Last 12 monthsHCASector median
Revenue growth+5.8%+7.8%
Free cash flow margin7.6%15.9%
Price to earnings15.7x30.2x

Stories on HCA Healthcare

We haven't written about HCA Healthcare yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Health Care Facilities, by market value.

CompanyPriceTodayYTDValue
LLYEli Lilly$1,417.54+3.19%+31.9%$1.33T
JNJJohnson & Johnson$273.20−0.73%+32.0%$658B
ABBVAbbVie$294.89+1.41%+29.1%$521B
MRKMerck$149.52+2.18%+42.0%$369B
UNHUnitedHealth$406.97−0.96%+23.3%$365B
NVSNovartis$160.79−0.19%+16.6%$327B
AZNAstraZeneca$186.65+7.02%+6.4%$290B
TMOThermo Fisher Scientific$697.00−1.72%+20.3%$258B